Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion type Assertion NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_head.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion description "[1) a subset of metastatic lobular breast carcinoma harbors FGFR-1 gene amplification or gains of chromogenic signals; 2) a minor heterogeneity has been observed after matching primary and metastatic carcinomas; 3) in the era of tailored therapies, patients affected by the lobular subtype of breast carcinoma with FGFR1 amplification could be approached to the new target biological therapy such as emerging FGFR-1 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_provenance.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion evidence source_evidence_literature NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_provenance.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion SIO_000772 23270564 NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_provenance.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion wasDerivedFrom befree-20140225 NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_provenance.
- NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_assertion wasGeneratedBy ECO_0000203 NP932230.RAQEfQNiKZwClqmeFUwkvR41bMhd45Bu7udFQk1Q8wgK4130_provenance.